Gene · 8741
Papers1,439
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,439
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway. | Int J Nanomedicine | 2023 | 38046235 | PubTator, text mining | PubMed |
| FOXD1 expression-based prognostic model for uveal melanoma. | Heliyon | 2023 | 38027647 | PubTator, text mining | PubMed |
| Targeting the Endothelin A Receptor in IgA Nephropathy. | Kidney Int Rep | 2023 | 38025243 | PubTator, text mining | PubMed |
| Editorial: Next generation B cell targeting therapies in autoimmune diseases. | Front Immunol | 2023 | 38022541 | PubTator, text mining | PubMed |
| CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond. | Vaccines (Basel) | 2023 | 38006053 | PubTator, text mining | PubMed |
| Association of Asymmetric and Symmetric Dimethylarginine with Inflammation in the Population-Based Study of Health in Pomerania. | Biomolecules | 2023 | 38002294 | PubTator, text mining | PubMed |
| The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome. | Nat Commun | 2023 | 37996443 | PubTator, text mining | PubMed |
| Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma. | Nat Commun | 2023 | 37980341 | PubTator, text mining | PubMed |
| Case Report: Telitacicept in treating a patient with NF155+ autoimmune nodopathy: a successful attempt to manage recurrent elevated sero-anti-NF155 antibodies. | Front Immunol | 2023 | 37965304 | PubTator, text mining | PubMed |
| Urine-derived stem cells in neurological diseases: current state-of-the-art and future directions. | Front Mol Neurosci | 2023 | 37965041 | PubTator, text mining | PubMed |
| Hofbauer cell function in the term placenta associates with adult cardiovascular and depressive outcomes. | Nat Commun | 2023 | 37963865 | PubTator, text mining | PubMed |
| Candidate Genes for IgA Nephropathy in Pediatric Patients: Exome-Wide Association Study. | Int J Mol Sci | 2023 | 37958966 | PubTator, text mining | PubMed |
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37958571 | PubTator, text mining | PubMed |
| Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration. | Front Aging | 2023 | 37900152 | PubTator, text mining | PubMed |
| Host Responses to Respiratory Syncytial Virus Infection. | Viruses | 2023 | 37896776 | PubTator, text mining | PubMed |
| Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease. | Biomedicines | 2023 | 37893187 | PubTator, text mining | PubMed |
| CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification. | Cells | 2023 | 37887301 | PubTator, text mining | PubMed |
| Mononuclear cells from patients with rhupus are influenced by TNF in their production of gp130/sIL-6Rb and APRIL. | Lupus Sci Med | 2023 | 37880158 | PubTator, text mining | PubMed |
| A Specialized Epithelial Cell Type Regulating Mucosal Immunity and Driving Human Crohn's Disease. | bioRxiv | 2023 | 37873404 | PubTator, text mining | PubMed |
| Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant. | Hepatol Commun | 2023 | 37870985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8741/papers?page=7